about
Metalloid compounds as drugsBoron chemicals in diagnosis and therapeuticsRecent advances in malaria drug discoveryA potent antimalarial benzoxaborole targets a Plasmodium falciparum cleavage and polyadenylation specificity factor homologueUtilization of Boron Compounds for the Modification of Suberoyl Anilide Hydroxamic Acid as Inhibitor of Histone Deacetylase Class II Homo sapiens.Co-expression analysis of differentially expressed genes in hepatitis C virus-induced hepatocellular carcinoma.Branched peptide boronic acids (BPBAs): a novel mode of binding towards RNA.HIV-1 drug discovery: targeting folded RNA structures with branched peptides.Click Chemistry in Lead Optimization of Boronic Acids as β-Lactamase Inhibitors.Antimalarial Benzoxaboroles Target Plasmodium falciparum Leucyl-tRNA Synthetase.A Divalent Protecting Group for Benzoxaboroles.Hollow boron nitride nanospheres as boron reservoir for prostate cancer treatment.Targeting Toxoplasma gondii CPSF3 as a new approach to control toxoplasmosis.Calcium fructoborate--potential anti-inflammatory agent.Boron-containing inhibitors of synthetases.Aminoboronic acids and esters: from synthetic challenges to the discovery of unique classes of enzyme inhibitors.Challenges and opportunities in developing novel drugs for TB.Boron as a platform for new drug design.Boron and nucleic acid chemistries: merging the best of both worlds.Molecular recognition with boronic acids-applications in chemical biology.Boron-containing compounds: chemico-biological properties and expanding medicinal potential in prevention, diagnosis and therapy.From the Test Tube to the Treatment Room: Fundamentals of Boron-containing Compounds and their Relevance to Dermatology.Potential new clinical therapies for Chagas disease.Azaborininones: Synthesis and Structural Analysis of a Carbonyl-Containing Class of Azaborines.Recent developments with boron as a platform for novel drug design.Sugar-boronate ester scaffold tethered pyridyl-imine palladium(II) complexes: synthesis and their in vitro anticancer evaluation.Detection of boronic acid derivatives in cells using a fluorescent sensor.Acylboranes: synthetic strategies and applications.An efficient 2D 11B-11B solid-state NMR spectroscopy strategy for monitoring covalent self-assembly of boronic acid-derived compounds: the transformation and unique architecture of bortezomib molecules in the solid state.Geometry of trigonal boron coordination sphere in boronic acids derivatives - a bond-valence vector model approach.Iridium-Catalyzed Allylic Amination Route to α-Aminoboronates: Illustration of the Decisive Role of Boron SubstituentsAntibacterial and Antibiofilm Effects of Boron on Different Bacteria.Small-molecule inhibitors prevent the genotoxic and protumoural effects induced by colibactin-producing bacteria.Detection of boronic acids through excited-state intramolecular proton-transfer fluorescenceAccessing Elaborated 2,1-Borazaronaphthalene Cores Using Photoredox/Nickel Dual-Catalytic Functionalization.C5 and C7 intramolecular hydrogen bonds stabilize the structure of N-pyrazinoyl-gabapentin (Pyr-Gpn-OH).Focusing on boron in medicinal chemistry.Activity of biapenem (RPX2003) combined with the boronate β-lactamase inhibitor RPX7009 against carbapenem-resistant Enterobacteriaceae.Synthesis, characterization, and antibacterial activity of structurally complex 2-acylated 2,3,1-benzodiazaborines and related compounds.Multicomponent mapping of boron chemotypes furnishes selective enzyme inhibitors.
P2860
Q26822682-4FE9B5AE-96BC-4211-B0DD-307A05490481Q27006075-7653917F-5136-4DDD-857F-7BF7A91CDC2AQ27010534-FCEFEB72-05BE-4A74-9C6C-0839A2AB290DQ30045921-C68B4243-F80B-423C-8449-21215A227EC3Q34151939-14C2FAE4-3ADD-43F7-A60A-E7B5AFBD07CEQ34540886-F22BEDD7-3E3F-42B6-9312-0C7A4E2E3F56Q34587957-AFDAAD29-CBA6-4B44-8C26-FF51668F9052Q35626292-A52D6E45-9178-45AC-B65A-579E8CA8DD2BQ35671797-F924A7F7-B66D-49B5-858E-0325AC81275BQ37120074-FF6AE758-3C1F-41A6-B468-F84C52E531A6Q37542650-121DC4A3-5534-40DA-B7CA-961ECF55D201Q37582113-C3A59A03-6E34-4F35-9458-1FE9A1B7FEB3Q37672675-442D4AC6-BBE5-49C4-9A85-496C20CFBA0AQ37832981-F500E6FE-2841-4709-BD7D-2FEFC4270A7DQ37836421-91DF1515-1201-4EB2-A9BD-AE8705A1052FQ37856761-4EA6435F-F62D-46D4-BB59-F339C32D0AB7Q37924294-B89B446D-8ADB-4731-BB02-DFD499B320F4Q38040432-2E88EC2C-961E-42BC-875A-A7ED8CCD7ADDQ38094018-A4CD46F1-5AC3-4AD1-B3A3-13556694501EQ38178990-9267D692-A5C6-4A28-89FB-AC58020BDC0AQ38181178-61014739-D173-48A0-8B21-59E8D3A55B02Q38191916-B178D981-87E3-4BB0-BF56-B0EB7ECF966AQ38203330-2C41A503-09A2-43CC-BB68-F15066A4C532Q38796099-29650299-DEFD-4DB2-9532-E06DFDFB872DQ38808788-BBFD8E21-CA3E-4201-9E56-B29748665604Q38833511-E60AFB84-E1E8-44AB-8312-DE080431656FQ38869760-DCAFEFB1-E63C-4626-A4C9-A2F5DF243210Q39026981-D1E972CA-726A-4DDB-89B7-FF13007DBFC6Q39140225-5878763A-8F77-4BC1-B8C0-B4BA56D16456Q39860462-252F565A-646B-42FB-9863-A3169485BA1EQ41231037-FAFF0E39-8676-460F-B0F2-072571B9346DQ41369163-0FF16D9E-8BD8-4BA3-89E4-A314380DBE77Q41583397-FF847C2D-9716-47BF-9CBD-C12E8917419CQ41844668-BA5CF181-88D1-4375-B7C9-879C5DAE20B8Q42284438-68B84E3A-0DD1-496D-B5C7-7888EA19C70EQ43833629-7D6A4862-9BBB-48F2-BB45-6917EDE93BCBQ44975010-B647D9F3-9D2B-4271-83A5-D6D26F0009EDQ45565740-8767BE9D-C1FC-4CBD-88DF-3CDD0BB49643Q46098028-613F2300-F907-403B-AC9D-CED5F4EB951BQ47104782-AC755235-798B-49F4-B12C-944439E05F26
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Therapeutic potential of boron-containing compounds.
@en
Therapeutic potential of boron-containing compounds.
@nl
type
label
Therapeutic potential of boron-containing compounds.
@en
Therapeutic potential of boron-containing compounds.
@nl
prefLabel
Therapeutic potential of boron-containing compounds.
@en
Therapeutic potential of boron-containing compounds.
@nl
P2093
P2860
P356
P1476
Therapeutic potential of boron-containing compounds.
@en
P2093
Charles Z Ding
Stephen J Baker
Tsutomu Akama
Vincent Hernandez
Yong-Kang Zhang
P2860
P304
P356
10.4155/FMC.09.71
P577
2009-10-01T00:00:00Z